Quantcast

Health Care Sector Update for 05/10/2017: PRTO


Shutterstock photo

Top Health-care stocks:

JNJ: -0.2%

PFE: -1.3%

ABT: flat

MRK: -0.1%

AMGN: flat

Health-care shares were mixed in pre-market trade on Wednesday.

In health-care stocks news, Proteon Therapeutics ( PRTO ) said early Wednesday its investigational treatment, vonapanitase, has received 'breakthrough therapy' designation from the U.S. Food and Drug Administration (FDA).

Shares in the company were 33.3% higher at $1.80 in pre-market trade on Wednesday. The stock has traded between $1.30 and $11.45 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.





This article appears in: Investing , US Markets
Referenced Symbols: PRTO



More from MT Newswires

Subscribe







MT Newswires
Contributor:

MT Newswires

Market News, Commodities












Research Brokers before you trade

Want to trade FX?